Understand the source comparison
Best Peptides for Repetitive Strain Injury: Compound Comparison
BPC-157 VEGF upregulation, fibroblast migration Tendon, ligament, gastric tissue 250–500 mcg 2×/day SC 4–6 hours Moderate (animal models, limited human trials) TB-500 Actin binding, tissue elasticity restoration Ligament, muscle, cardiac tissue 2–5 mg 2×/week
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, fibroblast migration
- Tendon, ligament, gastric tissue
- 250–500 mcg 2×/day SC
- 4–6 hours
- Moderate (animal models, limited human trials)
- TB-500
- Actin binding, tissue elasticity restoration
- Ligament, muscle, cardiac tissue
- 2–5 mg 2×/week loading, 2 mg/week maintenance
- 7–10 days
- Moderate (preclinical, anecdotal clinical use)
- Thymosin Beta-4 (full-length)
- Immune modulation, angiogenesis
- Chronic inflammation, delayed healing
- 5–10 mg weekly
- 10–14 days
- Moderate (veterinary, limited human data)
- Cerebrolysin
- BDNF/NGF neurotrophic support
- Nerve compression, neuropathy
- 5–10 mL IM 3×/week
- 2–4 hours (active peptides)
- Strong (European neurology trials, stroke recovery)
- MK-677
- GH/IGF-1 secretagogue
- Muscle strain, systemic recovery
- 10–25 mg oral daily
- Strong (sarcopenia, cachexia trials)
- KPV
- Anti-inflammatory (alpha-MSH analog)
- Acute inflammation phase
- 500 mcg–1 mg daily SC
- 6–8 hours
- Weak (theoretical mechanism, minimal trials)